Lhotse Medical, Inc. — Form D
Lhotse Medical, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-04. The offering totals $2.3M, of which $2.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-01-04
- Form: D
- Accession: 0002006837-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $2.2M
- Remaining: $105K
- Investors: 7
- Date of first sale: 2023-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-501563
Issuer
- Name: Lhotse Medical, Inc.
- CIK: 0002006837
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 7557 BENEDICT DRIVE, DALLAS, TX, 75214
- Phone: (415) 851-0337
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Carter Meyer | Director | South San Francisco, CA |
| Chris Kaster | Director | Dallas, TX |
| Anand Doraiswamy | Director | Dallas, TX |
| Anand Doraiswamy | Executive Officer | Dallas, TX |
| Josh Baltzell | Director | Dallas, TX |
Other filings by this issuer (1)
More